Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001.
about
Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liver.Surviving mousepox infection requires the complement systemMousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies.Poxvirus antigen staining of immune cells as a biomarker to predict disease outcome in monkeypox and cowpox virus infection in non-human primatesEctromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics.A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease.Therapeutic and prophylactic drugs to treat orthopoxvirus infectionsEvaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpoxThe attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus.Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012.[18F]-Fluorodeoxyglucose Uptake in Lymphoid Tissue Serves as a Predictor of Disease Outcome in the Nonhuman Primate Model of Monkeypox Virus Infection.Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox.The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak.
P2860
Q31045190-BCB79D87-4AB7-4602-ADEB-9A334087EC31Q33396210-BE9F41E1-1FF1-4901-A8A7-F87F70D5DDCEQ33570349-D6E12F8B-C062-41B1-8F0F-1ECDE9DEA5B5Q34663791-CA6EB1B7-8237-4383-8D0A-51372575E21EQ35261304-77115190-023D-4B5A-9461-781574A001E7Q36130201-4E24C3AD-0995-4F6D-830A-28B31EC8B88CQ37009973-6296E9EB-9F80-4590-B62B-CBD2DBC69344Q37043625-2B2764CD-C749-4DE9-8C4C-F1E17A7BBC9AQ37211150-3F1321FC-275F-4DB2-9660-978000FD19DBQ37593480-16A82BF7-7D07-46CE-8848-DB4F1A039913Q38621512-F157F3AF-71B2-4574-895A-7C2E72D8C019Q38957078-389213FE-C603-427F-9BD5-1BDD85AFD9C0Q47162853-1B740427-1680-4654-ACC4-68BB745D443B
P2860
Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Using biomarkers to stage dise ...... pox model treated with CMX001.
@en
Using biomarkers to stage dise ...... pox model treated with CMX001.
@nl
type
label
Using biomarkers to stage dise ...... pox model treated with CMX001.
@en
Using biomarkers to stage dise ...... pox model treated with CMX001.
@nl
prefLabel
Using biomarkers to stage dise ...... pox model treated with CMX001.
@en
Using biomarkers to stage dise ...... pox model treated with CMX001.
@nl
P2093
P2860
P1433
P1476
Using biomarkers to stage dise ...... pox model treated with CMX001.
@en
P2093
Alice Robertson
Christina Oberle
George Painter
Jill Schriewer
R Mark Buller
Randall Lanier
Scott Parker
P2860
P304
P577
2008-01-01T00:00:00Z